Insider buying · SEC Form 4

Insider Buying — Aug 7, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

3insider buys
$2.09Mbought in total
3companies
0by CEOs, CFOs and other chiefs
THRYlargest: $1.12M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
THRYThryv Holdings, Inc.Paulson & Co. Inc.10% Owner$1.12M399,548$2.81AddedAug 6, 2026
Form 4 ↗
Two tranches: 254,573 shares at $2.82 avg (Aug 4) + 144,975 shares at $2.79 avg (Aug 5). Total stake now ~8.84M shares. Thryv 8-K filed Aug 4 (potential earnings) — possible post-earnings accumulation. Pre-mkt bid $2.71, prev close $2.46 (−12.5% below avg cost).
LUMNLumen Technologies, Inc.Kathleen E. JohnsonDirector$613K100,000$6.13AddedAug 6, 2026
Form 4 ↗
Open-market purchase of 100K shares at wtd avg $6.1268 (range $6.065–$6.175) on Aug 5, held in revocable trust. Johnson's total LUMN stake: ~12.2M shares across direct + spousal trust + GRAT + revocable trust. Pre-mkt bid $6.16 (prev close $5.90, −3.7% below avg cost).
DMCDel Monte CorporationAbbas MohammedExecutive Director$359K12,000$29.89AddedAug 6, 2026
Form 4 ↗
Del Monte Corp rebranded from Fresh Del Monte Produce Inc. (FDP→DMC) on June 29, 2026. Bought 12,000 shares at wtd avg $29.8921 on Aug 4. Pre-mkt bid $30.38 (+1.6% above avg cost vs prev close $29.90).

AIThe day in insider buying

SEC Form 4 Insider Scan — August 7, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 3 qualifying buys (≥ $250K, transaction type P) totalling $2.1M.

Headline filings

  • THRY — Paulson & Co. Inc. (10% Owner) bought 399,548 shares ≈ $1.12M at $2.82/$2.79 avg across two tranches (Aug 4–5); now $2.46 prev close (−12.5% vs avg cost; pre-mkt bid $2.71). Paulson continues accumulating in Thryv Holdings — SMB SaaS platform — lifting total stake to ~8.84M shares. Thryv filed a Form 8-K on Aug 4 (possible earnings release), making this a potential post-earnings cluster buy. (filing)
  • LUMN — Kathleen E. Johnson (Director) bought 100,000 shares ≈ $613K at $6.13 wtd avg (range $6.065–$6.175); now $5.90 prev close (−3.7% vs cost; pre-mkt bid $6.16 ≈ flat vs cost). Post-bankruptcy Lumen Technologies insider adds to an already massive ~12.2M-share position held across direct and trust accounts. All shares purchased open-market on Aug 5. (filing)
  • DMC — Abbas Mohammed (Executive Director) bought 12,000 shares ≈ $359K at $29.89 avg; now $29.90 prev close (≈ flat vs cost; pre-mkt bid $30.38, +1.6%). Insider buy at Del Monte Corporation — which completed its rebranding from Fresh Del Monte Produce (FDP→DMC) on June 29, 2026, marking the first time the Del Monte® brand has operated under a single owner. (filing)

Notes

Light filing day — only 3 buys cleared the $250K bar across ~50 Form 4 disclosures reviewed for Aug 6–7. Notable near-miss: Marcus Lemonis (Exec. Chairman/CEO) bought 43,382 shares of Bed Bath & Beyond (BBBY) at $4.67 avg ≈ $202.6K — just under the threshold.

Themes: (1) Distressed/post-restructuring recovery names dominate — THRY and LUMN are both names that have gone through significant capital restructuring; repeat insider conviction buying here is a meaningful signal. (2) Brand consolidation thesis at DMC — the newly rebranded Del Monte Corp executive is buying into the company's first integrated global brand strategy in decades. Price quotes reflect pre-market conditions (Aug 7 open not yet recorded); Δ% vs buy price uses prior-day close as current price proxy.

Most-bought stocks, last 30 days

  • AVO $60.1M · 8 buysMission Produce, Inc.
  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $42.9M · 7 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • LBRX $10.0M · 1 buyLB Pharmaceuticals Inc.
  • BSX $9.00M · 1 buyBoston Scientific Corp
  • NTSK $7.53M · 2 buys, 2 insidersNetskope Inc.
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • APMD $5.00M · 1 buyApnimed, Inc.
  • GSHD $4.49M · 3 buysGoosehead Insurance, Inc.
  • GLOO $3.50M · 1 buyGloo Holdings, Inc.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • CSGP $2.49M · 1 buyCoStar Group, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • CLBK $2.13M · 5 buys, 5 insidersColumbia Financial, Inc.
  • GGAL $2.09M · 1 buyGrupo Financiero Galicia S.A.
  • ENR $2.02M · 1 buyEnergizer Holdings, Inc.
  • PFE $1.96M · 2 buys, 2 insidersPfizer Inc
  • TM $1.56M · 1 buyToyota Motor Corp

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.